Paragraph 6
United Kingdom
One or more of the indications for the medicinal product consistent with the terms of the F1UK marketing authorisation F2..., certificate of registration, traditional herbal registration or Article 126a authorisation for the product F3or, in the case of a product in relation to which there is in force an authorisation by the licensing authority on a temporary basis under regulation 174, the indications for the medicinal product consistent with the recommendation or requirement of the licensing authority as to the use of that product.
Annotations
Textual amendments
- F1
Words in Sch. 30 para. 6 substituted (31.12.2020) by S.I. 2019/775, reg. 216(a) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 175)
- F2
Words in Sch. 30 para. 6 omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 144(c)
- F3
Words in Sch. 30 para. 6 inserted (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.I. 2020/1125), regs. 1(2), 33(3) and words in Sch. 30 para. 6 inserted (N.I.) (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.R. 2020/349), regs. 1(2), 33(3)